View our masking and visitation guidelines based on current rates of respiratory illnesses in the community.

Our new building on the hospital campus, Forest B, is open. Families and visitors can park in the new Forest B garage next to Emergency.

Clinical Trial Search block Test

A Phase 1 Study of FOLR1 CAR T for Pediatric Patients with Relapsed or Refractory AML

FOLR1 CAR T

Condition(s): Myeloid and Monocytic Leukemia
Phase: I
Clinicaltrials.gov ID: NCT06609928

What is the goal of the study?

This phase 1, open-label, non-randomized study will enroll pediatric patients with relapsed or refractory FOLR1+ acute myeloid leukemia with and without prior history of allogeneic hematopoietic cell transplantation, to examine the safety and feasibility of administering an autologous T cell product that has been genetically modified to express FOLR1 CAR.

Who can participate in the study?

Everyone

Study Team:

PI (Study Doctor): Katherine Tarlock
Study Team Member: HemOnc CRAs, hemonccras@seattlechildrens.org